Actionable insights straight to your inbox

Equities logo

The Life Sciences Report

The Life Sciences Report: Featuring investment ideas in biotechnology, pharmaceuticals, medical devices, tools and diagnostics in interviews with industry-sector experts–analysts, money managers and newsletter writers–backed by the latest research summaries, news and company profiles. It's a combination of information and insight investors can't get anywhere else.
G1 Therapeutics Inc. (GTHX:NASDAQ) began two Phase Two clinical trials of Cosela (trilaciclib) in patients with early-stage triple negative breast cancer (TNBC), H.C. Wainwright & Co. analyst Edwar...